UBS O'Connor’s Alder Biopharmaceuticals ALDR Stock Holding History

UBS O'Connor’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,248,003	Closed	-$23.5M	–	406
2019 Q3	$23.5M	Buy	+1,248,003	New	+$14.3M	0.65%	29
2016 Q3	–	Sell	-55,000	Closed	-$1.37M	–	529
2016 Q2	$1.37M	Buy	+55,000	New	+$1.49M	0.03%	276
2015 Q2	–	Sell	-25,000	Closed	-$722K	–	947
2015 Q1	$722K	Buy	+25,000	New	+$686K	0.02%	450

UBS O'Connor's ALDR Position: Q4 2019 in Review

UBS O'Connor sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 1,248,003 shares — an estimated $23.5M sold.

UBS O'Connor first reported a position in ALDR in Q1 2015 and held it in 3 quarters. The position peaked at $23.5M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

UBS O'Connor reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
UBS O'Connor sold 1,248,003 Alder Biopharmaceuticals shares in Q4 2019, an estimated $23.5M.
UBS O'Connor first reported a position in Alder Biopharmaceuticals in Q1 2015 and held it in 3 quarters.
UBS O'Connor's Alder Biopharmaceuticals position peaked at $23.5M in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on UBS O'Connor's 13F filing for Q4 2019, filed 14 Feb 2020.